Kristine Ann Blackham

Kristine Ann Blackham

Auto-generated profile, based on publicly available information

Kristine Ann Blackham

From the University Hospital of Basel (K.A.B.), Dept of Radiology and Nuclear Medicine, Neuroradiology, Petersgraben 4, Basel 4056, Switzerland

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
MSMuhannad Seyam
Muhannad Seyam
TWThomas Weikert
Thomas Weikert
ASAlexander Sauter
Alexander Sauter
ABAlex Brehm
Alex Brehm
MPMarios-Nikos Psychogios
Marios-Nikos Psychogios
KBKristine A. Blackham
Kristine A. Blackham
“Just Accepted” papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review ...

6 February 2020 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
CMC.J. Maurer
C.J. Maurer
TDT. Dobrocky
T. Dobrocky
FJF. Joachimski
F. Joachimski
UNU. Neuberger
U. Neuberger
TDT. Demerath
T. Demerath
Sebastian FischerSebastian Fischer
Sebastian Fischer
BACKGROUND AND PURPOSE: Large intracranial vessel occlusion due to calcified emboli is a rare cause of major stroke. We assessed the prevalence, imaging appearance, the effectiveness of mechanical thrombectomy, and clinical outcome of patients with large-vessel occlusion due to calcified emboli. MATERIALS AND METHODS: We performed a retrospective analysis of clinical and procedural data of consecutive patients who underwent mechanical thrombectomy due to calcified emboli in 7 European stroke centers. RESULTS: We screened 2969 patients, and 40 patients matched the inclusion criteria, accounting for a prevalence of 1.3%. The mean maximal density of the thrombus was 327 HU (range, 150–1200 HU), and the mean thrombus length was 9.2 mm (range, 4–20 mm). Four patients had multiple calcified emboli, and 2 patients had an embolic event during an endovascular intervention. A modified TICI score of ≥2b was achieved in 57.5% (23/40), with minimal-to-no reperfusion (modified TICI 0–1) in 32.5% (13/40) and incomplete reperfusion (modified TICI 2a) in 10% (4/40). Excellent outcome (mRS 0–1) was achieved in only 20.6%, functional independence (mRS 0–2) in 26.5% and 90-day mortality was 55.9%. CONCLUSIONS: Acute ischemic stroke with large-vessel occlusion due to calcified emboli is a rare entity in patients undergoing thrombectomy, with considerably worse angiographic outcome and a higher mortality compared with patients with noncalcified thrombi. Good functional recovery at 3 months can still be achieved in about a quarter of patients.

30 November 2016 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
NMNauman F. Manzoor
Nauman F. Manzoor
RRRod P. Rezaee
Rod P. Rezaee
ARAbhishek Ray
Abhishek Ray
CWCameron C. Wick
Cameron C. Wick
KBKristine Blackham
Kristine Blackham
CZChad A. Zender
Chad A. Zender

7 February 2019 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
JOJ.M. Ospel
J.M. Ospel
GGG. Gascou
G. Gascou
VCV. Costalat
V. Costalat
LPL. Piergallini
L. Piergallini
KBK.A. Blackham
K.A. Blackham
DZD.W. Zumofen
D.W. Zumofen
BACKGROUND AND PURPOSE: The Sim&Size software simulates case-specific intraluminal Pipeline Embolization Device behavior, wall apposition, and device length in real-time on the basis of rotational angiography DICOM data. The purpose of this multicenter study was to evaluate whether preimplantation device simulation with the Sim&Size software results in selection of different device dimensions than manual sizing. MATERIALS AND METHODS: In a multicenter cohort of 74 patients undergoing aneurysm treatment with the Pipeline Embolization Device, we compared apparent optimal device dimensions determined by neurointerventionalists with considerable Pipeline Embolization Device experience based on manual 2D measurements taken from rotational angiography with computed optimal dimensions determined by Sim&Size experts blinded to the neurointerventionalists9 decision. Agreement between manually determined and computed optimal dimensions was evaluated with the Cohen κ. The significance of the difference was analyzed with the Wilcoxon signed rank test. RESULTS: The agreement index between manual selection and computed optimal dimensions was low (κ for diameter = 0.219; κ for length = 0.149, P < .01). Computed optimal device lengths were significantly shorter (median, 14 versus 16 mm, T = 402, r = −0.28, P < .01). No significant difference was observed for device diameters. CONCLUSIONS: Low agreement between manually determined and computed optimal device dimensions is not proof, per se, that virtual simulation performs better than manual selection. Nevertheless, it ultimately reflects the potential for optimization of the device-sizing process, and use of the Sim&Size software reduces, in particular, device length. Nevertheless, further evaluation is required to clarify the impact of device-dimension modifications on outcome.

1 January 2011 in Journal of Neurosurgery
Verified
Journal Article
Closed access
KBKristine A. Blackham
Kristine A. Blackham
The author presents a novel endovascular treatment approach to extensive dural venous sinus thrombosis using the Penumbra clot aspiration system and local administration of recombinant tissue plasminogen activator. The clinical course, technical treatment aspects, and follow-up are described.

26 December 2019 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
JOJ.M. Ospel
J.M. Ospel
CWC.H. Wright
C.H. Wright
RJR. Jung
R. Jung
LVL.L.M. Vidal
L.L.M. Vidal
SMS. Manjila
S. Manjila
KBK.A. Blackham
K.A. Blackham
SUMMARY: Reversible vasoconstriction syndrome is a complex of clinical symptoms and angiographic findings, which, while having a mostly benign clinical course, has clinical and imaging overlap with more serious disorders such as vasculitis and aneurysmal SAH and itself includes a minority of patients with fulminant vasoconstriction resulting in severe intracranial complications. Endovascular options for patients with refractory reversible cerebral vasoconstriction syndrome include intra-arterial vasodilator infusion similar to therapy for patients with vasospasm after SAH. To date, only case reports and 1 small series have discussed the utility of intra-arterial vasodilators for the treatment of reversible cerebral vasoconstriction syndrome. We report an additional series of 11 medically refractory cases of presumed or proved reversible cerebral vasoconstriction syndrome successfully treated with intra-arterial verapamil infusion. Furthermore, we propose that the reversal of vasoconstriction, as seen on angiography, could fulfill a diagnostic criterion.